PARKHILL KAREN L 4
4 · Medtronic plc · Filed Aug 6, 2024
Insider Transaction Report
Form 4Exit
PARKHILL KAREN L
EVP & Chief Financial Officer
Transactions
- Exercise/Conversion
Ordinary Shares
[F1]2024-08-02+7,132→ 53,459 total - Tax Payment
Ordinary Shares
[F2]2024-08-02$81.51/sh−3,148$256,593→ 50,311 total - Tax Payment
Ordinary Shares
[F3]2024-08-02$81.51/sh−3,581$291,887→ 46,730 total - Exercise/Conversion
Performance Share Units
[F5][F6]2024-08-02−7,132→ 0 total→ Performance Share Units (7,132 underlying)
Holdings
- 49,859(indirect: By Trust)
Ordinary Shares
[F4] - 843(indirect: By Children)
Ordinary Shares
- 843(indirect: By Children)
Ordinary Shares
- 843(indirect: By Children)
Ordinary Shares
Footnotes (6)
- [F1]Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents.
- [F2]Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.
- [F3]Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.
- [F4]These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary.
- [F5]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
- [F6]The performance share units vested on August 2, 2024.
Signature
/s/ Thomas L. Osteraas, attorney-in-fact|2024-08-06